Company: OSRH
Filing Date: 2025-11-12
Form Type: 10-Q
Source: 0001213900-25-109054
Chunk: 41

Company: OSR Holdings, Inc.
Filing Date: 2025-11-12
Form: 10-Q
Item: Part I, Item 1
Chunk 41
---
     -236,923  
     7%
  
    Other income (expense) 
     70,448  
     (686,361) 
     -756,809  
     -1,074%
  
    Profit (loss) before income taxes 
     (3,496,094) 
     (4,489,826) 
     -993,732  
     28%

    Nine Months Ended September 30, 

    2024  
    2025  
    Change $  
    Change % 
  
    Net Sales: 
     2,615,051  
     2,524,536  
     -90,515  
     -3%
  
    Cost of Sales 
     1,963,835  
     2,061,335  
     97,500  
     5%
  
    Gross Profit 
     651,215  
     463,201  
     -188,014  
     -29%
  
    Expenses: 

    Selling, general and administrative expenses 
     10,730,393  
     12,413,670  
     1,683,277  
     16%
  
    Operating loss 
     (10,079,178) 
     (11,950,469) 
     -1,871,291  
     19%
  
    Other income (expense) 
     (23,392) 
     (9,157,369) 
     -9,133,977  
     39,047%
  
    Profit (loss) before income taxes 
     (10,102,570) 
     (21,107,838) 
     -11,005,268  
     109%

Net Sales, Cost of Sales, Gross Profit

OSR Holdings’ net sales, cost of sales, and gross profit are
primarily derived from RMC, its subsidiary engaged in the distribution of medical devices.

For the three months ended September 30, 2025, RMC’s net sales decreased by $195,249, or 24%, compared to the same period in the
prior year. However, cost of sales decreased by $277,889, or 43%, resulting in an increase in gross profit of $82,641, or 46